OpenAI released a new benchmark called LifeSciBench on Tuesday, designed to measure how well AI models perform on life sciences tasks. The company said the set of tests covers areas like molecular biology, genetics, and drug discovery — fields where accurate AI reasoning could speed up research but where errors carry high stakes.
What LifeSciBench covers
The benchmark includes dozens of challenges pulled from real scientific problems. Tasks range from predicting protein structures to analyzing gene expression data and interpreting clinical trial results. Each question was reviewed by domain experts to ensure it tests genuine scientific understanding rather than pattern matching.
OpenAI researchers argue that existing benchmarks often rely on multiple-choice questions that don't reflect how scientists actually work. LifeSciBench tries to mimic the kind of open-ended reasoning a researcher would do when designing an experiment or interpreting a lab result. That means the AI has to show its work — it can't just pick the right answer from a list.
Why a life sciences benchmark matters
AI tools are already being used to scan medical literature, suggest drug candidates, and even design new proteins. But the consequences of a wrong prediction in biology can be serious: a flawed model might recommend a toxic compound or miss a critical interaction. Without rigorous evaluation, researchers and regulators have no way to tell which models are reliable for which tasks.
LifeSciBench isn't the first benchmark in this space, but it's one of the most comprehensive from a major AI lab. The company said it hopes the benchmark becomes a standard test for any AI system claiming to work in the life sciences.
What happens next
OpenAI has made the benchmark publicly available on GitHub, and it plans to update it as new scientific challenges emerge. The company also said it will publish results from its own models on LifeSciBench in the coming weeks, giving the research community a baseline to compare against. Whether other AI labs adopt the benchmark — and how their models stack up — remains an open question.
